|
|
""BCR/ABL-PI-3k-ROS pathway induce genomic instability ....""
|
5R01CA134458-05
|
$298,713
|
$298,713
|
SKORSKI, TOMASZ
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
|
""Oncorequisite"" Genes in MYC-mediated Transformation
|
5R00CA134743-05
|
$234,037
|
$187,230
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
(PDQ5)Integrated Genetic and Epigenetic Prognostication for Acute Myeloid Leukemi
|
1R21CA185365-01
|
$243,600
|
$243,600
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
|
1R01CA185062-01
|
$310,254
|
$310,254
|
FARRAR, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
|
(PQB5) Epigenetic Drivers of Hematopoietic Stem Cell Transformation
|
1R21CA184851-01
|
$230,463
|
$230,463
|
TROWBRIDGE, JENNIFER
|
JACKSON LABORATORY
|
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
1R01CA185486-01
|
$517,690
|
$258,845
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
|
1R01CA184922-01
|
$553,684
|
$553,684
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
|
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
|
5R01CA180037-02
|
$318,099
|
$318,099
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
$269,060
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-03
|
$338,142
|
$169,071
|
PFEIFER, GERD
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???
|
5R01CA158275-05
|
$303,926
|
$303,926
|
CROOKS, PETER
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120 - 02060
|
$286,453
|
$114,581
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
|
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE CHROMOSOMAL ABERRATIONS AND RELATED BIOMarkERS IN GUANGZHOU CHINA
|
ZIA CP010121 - 10363
|
$43,721
|
$43,721
|
Lan, Qing
|
DCEG (NCI)
|
|
|
A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia
|
5U01CA174844-02
|
$465,155
|
$465,155
|
RADER, CHRISTOPH
|
SCRIPPS FLORIDA
|
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-05
|
$339,713
|
$84,928
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
|
1R01CA183252-01A1
|
$531,196
|
$531,196
|
GOODELL, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Novel Epigenetic Circuit in Acute Leukemia
|
1R21CA187276-01
|
$169,650
|
$169,650
|
HUANG, GANG
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
|
1K99CA183914-01A1
|
$169,668
|
$169,668
|
WAN, LIXIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Novel Role for PML bodies in Leukemic Transformation
|
1F32CA189413-01
|
$53,282
|
$53,282
|
COGSWELL, ALEXIS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
A Novel sequencing-based approach to discovering rare genetic factors for ALL.
|
5K08CA140720-05
|
$149,387
|
$149,387
|
DRULEY, TODD
|
WASHINGTON UNIVERSITY
|
|
|
A Pathway of Tumor Suppression
|
5R01CA047296-26
|
$242,092
|
$79,890
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$225,712
|
$22,571
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer
|
5R01CA168900-03
|
$322,040
|
$161,020
|
POWELL, DANIEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,076,623
|
$53,831
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
|
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
|
5K08CA160660-04
|
$156,330
|
$156,330
|
KENTSIS, ALEX
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
$5,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
$521,479
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Actin dynamics as a therapeutic target for Bcr-Abl-positive acute lymphoblastic l
|
1R15CA191476-01
|
$453,000
|
$453,000
|
DAI, ZONGHAN
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$381,093
|
$190,546
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Acute Myeloid Leukemia: MRD Analysis Using Modular uFluidics and uFlow Cytometry
|
5R21CA173279-02
|
$276,058
|
$276,058
|
SOPER, STEVEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$613,610
|
$613,610
|
Fry, Terry
|
CCR (NCI)
|
|
|
Adult Leukemia Research Center
|
5P01CA018029-39
|
$4,098,686
|
$3,319,936
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Aging-associated alterations in adaptive landscapes and the evolution of leukemia
|
3R01CA180175-02S1
|
$53,912
|
$53,912
|
DEGREGORI, JAMES
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Aging-associated alterations in adaptive landscapes and the evolution of leukemia
|
5R01CA180175-02
|
$309,492
|
$309,492
|
DEGREGORI, JAMES
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Agricultural Health Study - BioMarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 - 10527
|
$1,102,766
|
$441,106
|
Alavanja, Michael
|
DCEG (NCI)
|
|
|
ALL immunobiology and the bone marrow niche
|
ZIA BC 011295
|
$262,976
|
$262,976
|
Fry, Terry
|
CCR (NCI)
|
|
|
ALL therapy and developing brains: MRI measures, genetic factors and cognition
|
5R01CA090246-09
|
$368,817
|
$368,817
|
REDDICK, WILBURN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
1U10CA180821-01
|
$10,540,919
|
$1,581,138
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S1
|
$228,063
|
$34,209
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S2
|
$264,661
|
$39,699
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S3
|
$16,838
|
$2,526
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-04
|
$170,100
|
$170,100
|
BLEAKLEY, MARIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$209,461
|
$140,339
|
Kochenderfer, James
|
CCR (NCI)
|
|
|
Alloreactive Regulatory T cells control GVHD and maintain GVL effect
|
5R01CA118116-07
|
$256,112
|
$256,112
|
YU, XUE-ZHONG
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Alternative RNA splicing and protein products in leukemia outcome (PQ11)
|
5R01CA170250-03
|
$578,639
|
$578,639
|
NESS, SCOTT
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
Analysis of higher order chromatin structures in normal and cancer epigenomes
|
5R01CA140485-05
|
$323,118
|
$323,118
|
KIM, TAE HOON
|
YALE UNIVERSITY
|
|
|
Analysis of Initiating Events in Inv(16) Associated Acute Myeloid Leukemia
|
5R00CA148963-03
|
$241,530
|
$241,530
|
HYDE, RICIA
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,360,387
|
$68,019
|
Oberholtzer, J.
|
CCR (NCI)
|
|
|
Apoptosome Regulation in Leukemia by Protein Phosphatase 5 Hypoacetylation
|
5F31CA174243-02
|
$32,731
|
$32,731
|
FOSS, KRISTEN
|
DUKE UNIVERSITY
|
|
|
ARID5B and disparities of childhood leukemia
|
1U01CA176063-01A1
|
$388,534
|
$388,534
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Total relevant funding to Leukemia for this search: $236,731,918
|
